The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
about
The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product DevelopmentA review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsRisk drinking and contraception effectiveness among college womenIntravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Development of topical microbicides to prevent the sexual transmission of HIVContraception for adolescents with lupus.An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women.What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based surveyAdolescent experiences with the vaginal ringMatched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use.A temperature-monitoring vaginal ring for measuring adherence.New hormonal contraceptives: a comprehensive review of the literature.Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introductionThe combined contraceptive vaginal device (NuvaRing): a comprehensive review.Advances in the management of endometriosis: an update for clinicians.Vaginal delivery of contraceptives.An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV TransmissionThe combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Efficacy of combined contraceptive vaginal ring versus oral contraceptive pills in achieving hypothalamic-pituitary-ovarian axis suppression in egg donor in vitro fertilization cycles.Treatment satisfaction instruments for different purposes during a product's lifecycle: keeping the end in mind.Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.Vaginal health in contraceptive vaginal ring users - A review.Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health.Hot-melt extrusion--basic principles and pharmaceutical applications.Advanced topical drug delivery system for the management of vaginal candidiasis."Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review.Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.Prevalence of combined contraceptive vaginal rings in Norway.Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal.Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report.Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use.High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices.
P2860
Q28551783-093B88BB-6FC2-44BD-847A-7759BC72ED99Q30369008-3F0AF246-D4DA-40C6-BE1A-21204EA3F4D6Q30411138-D1E9E1DB-0676-4DA6-A731-F816AA563EECQ30447923-E6F8E7A1-2161-4ADF-94EE-B37C7D943B0FQ33625073-495E26F4-66F3-443E-A1D0-8BE3C57E3F62Q33813399-49362001-F693-4587-B672-50BEEB54F76EQ34141759-434F80D6-C64C-4A10-9026-EE864AB0FAE2Q34345741-B37017FB-5581-4352-89D8-82FA7DBD83F8Q34642459-CCE4226F-2663-409D-AAF6-E51374ACF75FQ34785676-FF8034A7-39D5-41E9-A05E-398C77FB8142Q35156426-F1123C73-CF01-40D7-BC7F-AC84F2C101BEQ35446476-14FA3801-D14D-4BED-BAE0-70DB8FBD0AF8Q35598595-75B71C7C-5963-417C-AA7F-FA61C890B920Q35616157-1CDA5D94-D325-4241-80D5-1CE719D29348Q36108786-E5B20E36-6D78-451C-9C5F-BE447999E3CFQ36251407-CB020CB7-6BA3-4033-81C1-F2FBC1113A2DQ36310331-F91F972B-DA10-4C9E-A71D-4C69E9922442Q36316884-388F39F6-2D40-49B1-B33E-5B45811FABE5Q36770118-1363E266-97F4-4F67-91EE-367D318A5167Q36904918-806C522E-3E52-4771-9735-FA021188A0FCQ36939490-53703C49-3725-4BD2-A45D-39E48FA462CBQ37255082-8216331A-29F0-4F88-849B-7AA15190D9C4Q37548016-67D7CC3F-17CA-4732-AD85-9CAEDE7AE2CCQ37945331-A5A8E2E4-6A84-4A6B-B9DF-9CC8C2672769Q37990037-79910BA5-730D-4C11-BE99-C1F09A57AA43Q38116095-CE662E3B-AACE-42C7-BE61-23252B46E431Q38132846-7A02FC31-FC36-43BF-8B23-93E9176A5E56Q38187427-C4F8E322-0CD4-42BB-8D0B-36F6559357AFQ38222794-5E4874D0-02C3-497C-A09E-6813FE8B83C1Q38664714-9176AB8B-1F98-49EE-A60F-3536D2F97290Q39265131-B818AE38-A5A3-49EA-AB49-5707B6168260Q39665889-F6DD905D-00B6-4EB7-AB28-A119709C4C17Q40030821-304B8C97-6ADA-4FCA-B11F-8F0CD306991AQ41588595-06C97C0F-2CD4-47FC-AE9F-BA92F01E1F1BQ42630326-22DE2F55-B54A-4840-BCEF-318F77A87F8DQ42844934-69106943-34EA-4974-968A-9D12BC6CBC60Q43521079-0BB4B5EE-9808-48EB-ADA1-7D8B6597A2C2Q43938676-5B5F3AE8-CD24-4151-8604-20645A6D8C36Q43938869-9B844F3E-E61B-4D63-BE01-0D0917C9F2A9Q45010869-034BAA0C-87EA-4474-9A47-5C18EAE3BB18
P2860
The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The combined contraceptive vag ...... l study of user acceptability.
@en
The combined contraceptive vag ...... l study of user acceptability.
@nl
type
label
The combined contraceptive vag ...... l study of user acceptability.
@en
The combined contraceptive vag ...... l study of user acceptability.
@nl
prefLabel
The combined contraceptive vag ...... l study of user acceptability.
@en
The combined contraceptive vag ...... l study of user acceptability.
@nl
P2093
P1433
P1476
The combined contraceptive vag ...... l study of user acceptability.
@en
P2093
de la Loge C
van der Meulen EA
P304
P356
10.1016/S0010-7824(02)00514-0
P577
2003-03-01T00:00:00Z